OSU-T315 as an Interesting Lead Molecule for Novel B Cell-Specific Therapeutics

B cells are pathogenic in various disease processes and therefore represent an interesting target for the development of novel immunosuppressants. In the search for new therapeutic molecules, we utilized an in vitro B cell activation assay with ODN2006-stimulated Namalwa cells to screen a chemical l...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Belle, Kristien, Herman, Jean, Waer, Mark, Sprangers, Ben, Louat, Thierry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157143/
https://www.ncbi.nlm.nih.gov/pubmed/30276218
http://dx.doi.org/10.1155/2018/2505818

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6157143/
https://www.ncbi.nlm.nih.gov/pubmed/30276218
http://dx.doi.org/10.1155/2018/2505818

Ejemplares similares